EMA Committee Recommends Yuviwel Approval for Children With Achondroplasia
The European Medicines Agency’s Committee for Medicinal Products for Human Use recommended granting marketing authorization for Ascendis Pharma’s Yuviwel treatment for children with achondroplasia.
Kelly CloonanA committee from the European Medicines Agency recommending granting marketing authorization for Ascendis Pharma's treatment for achondroplasia in children.The EMA's Committee for Medicinal Products for Human Use said Friday that Ascendis's Yuviwel drug will be available in several dos…